Real-time enrollment status for this cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:04 AM UTC
| NCT Number | NCT06385925 |
| Recruiting Status | Recruiting |
| Condition | Cancer |
| Phase | PHASE1 |
| Target Enrollment | 440 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Tyligand Pharmaceuticals (Suzhou) Limited |
| Last Updated on CT.gov | April 24, 2026 (Apr 24, 2026) |
As of July 17, 2026: Clinical trial NCT06385925 is currently recruiting participants. This phase1 study for cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Tyligand Pharmaceuticals (Suzhou) Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06385925 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06385925 was last updated Apr 24, 2026 (April 24, 2026). HelloStudys verifies this status automatically.